Crescendo Biologics Shortlisted for ‘Licensing Deal of the Year’ at the Scrip Awards 2017

Crescendo Biologics is pleased to announce that it has been shortlisted for ‘Licensing Deal of the Year’ at the Scrip Awards 2017.

Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017

Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017

view PDF

Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs

Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs.

view PDF